CCL21/CCR7 promotes G2/M phase progression via the ERK pathway in human non-small cell lung cancer cells.
about
Fine mapping reveals that promotion susceptibility locus 1 (Psl1) is a compound locus with multiple genes that modify susceptibility to skin tumor developmentThe role of chemoattractant receptors in shaping the tumor microenvironment.CCL21/CCR7 prevents apoptosis via the ERK pathway in human non-small cell lung cancer cells.Type 10 soluble adenylyl cyclase is overexpressed in prostate carcinoma and controls proliferation of prostate cancer cellsMicroRNA-181a suppresses mouse granulosa cell proliferation by targeting activin receptor IIAThe role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis.RETRACTED: Growth inhibition and apoptosis induced by 6-fluoro-3-formylchromone in hepatocellular carcinoma.CCL21/CCR7 enhances the proliferation, migration, and invasion of human bladder cancer T24 cells.COPD promotes migration of A549 lung cancer cells: the role of chemokine CCL21.CCR7 expression and intratumoral FOXP3+ regulatory T cells are correlated with overall survival and lymph node metastasis in gastric cancer.FAM46C is critical for the anti-proliferation and pro-apoptotic effects of norcantharidin in hepatocellular carcinoma cells.CC-chemokine receptor 7 is overexpressed and correlates with growth and metastasis in prostate cancer.Prevention of ERK activation involves melatonin-induced G(1) and G(2) /M phase arrest in the human osteoblastic cell line hFOB 1.19.CCR7/p-ERK1/2/VEGF signaling promotes retinal neovascularization in a mouse model of oxygen-induced retinopathy.MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1.Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors.
P2860
Q33784939-EFC5D570-2D1D-4AF0-96E8-33072B96C6F5Q33993124-39A36BBD-31FA-4993-9337-D8F985C65F36Q34206158-36CC6D7C-DBE8-408E-8DF2-67C573DE2EDCQ34318699-A7283117-B80A-4D7D-AA1E-53B3999D5F6BQ34635406-559FD0A7-1E77-4133-876B-86B6E291C20FQ35117974-C93D2985-CB42-486E-999A-B8CA35FA0D5DQ35140999-575F230D-7DBC-49D4-8C33-32B7B87F10F5Q35583823-F4B7A739-4831-4DEC-88DC-E53448E48168Q36955681-1CC1F315-B9FE-4D6A-91B1-FF753883E239Q37149721-D39FA7E9-E3EF-459B-A2D6-FAEE58680140Q38877274-32529F1F-73D9-46EF-BABE-6C0610D4E0C6Q38909580-63ED5A41-E0E7-4333-B9B1-51B619FCC985Q39460149-E9CDF3D7-F16C-45C1-8050-05C20AE90FE5Q41045765-64999086-F335-4BCF-BFD5-AB281ED29590Q41994436-E13D5A2E-C5B9-4F41-9D9A-6482AAE04136Q51472977-C9554BAC-5724-4B57-B8F3-ACFA9F2389BB
P2860
CCL21/CCR7 promotes G2/M phase progression via the ERK pathway in human non-small cell lung cancer cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
CCL21/CCR7 promotes G2/M phase ...... -small cell lung cancer cells.
@ast
CCL21/CCR7 promotes G2/M phase ...... -small cell lung cancer cells.
@en
type
label
CCL21/CCR7 promotes G2/M phase ...... -small cell lung cancer cells.
@ast
CCL21/CCR7 promotes G2/M phase ...... -small cell lung cancer cells.
@en
prefLabel
CCL21/CCR7 promotes G2/M phase ...... -small cell lung cancer cells.
@ast
CCL21/CCR7 promotes G2/M phase ...... -small cell lung cancer cells.
@en
P2093
P2860
P1433
P1476
CCL21/CCR7 promotes G2/M phase ...... -small cell lung cancer cells.
@en
P2093
Enhua Wang
Haiying Li
Lifeng Liu
Lili Jiang
Wenting Luo
Xueshan Qiu
P2860
P304
P356
10.1371/JOURNAL.PONE.0021119
P407
P577
2011-06-16T00:00:00Z